Key players in Biosimilar Development Services
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Samsung Biologics | — | 99 reports |
| 2 |  Celltrion |
celltrion.com (opens in a new tab) | 99 reports |
| 3 | WuXi Biologics | — | 66 reports |
| 4 | Intas Pharmaceuticals | — | 33 reports |
| 5 | Syngene International | — | 33 reports |
Biosimilar Development Services reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Biosimilar Development Services report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.